NeuroOne Medical Technologies Corporation
NMTC · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $35,680 | $26,495 | $16,135 | $27,038 |
| - Cash | $6,570 | $1,460 | $5,322 | $8,160 |
| + Debt | $143 | $260 | $184 | $203 |
| Enterprise Value | $29,253 | $25,295 | $10,997 | $19,080 |
| Revenue | $9,098 | $3,453 | $1,952 | $171 |
| % Growth | 163.5% | 76.9% | 1,040.7% | – |
| Gross Profit | $5,141 | $1,080 | $457 | -$71 |
| % Margin | 56.5% | 31.3% | 23.4% | -41.4% |
| EBITDA | -$4,226 | -$11,842 | -$11,756 | -$9,912 |
| % Margin | -46.5% | -343% | -602.1% | -5,790.9% |
| Net Income | -$3,605 | -$12,318 | -$11,859 | -$10,000 |
| % Margin | -39.6% | -356.7% | -607.4% | -5,842% |
| EPS Diluted | -0.09 | -0.46 | -0.65 | -0.63 |
| % Growth | 80.4% | 29.2% | -3.2% | – |
| Operating Cash Flow | -$2,837 | -$11,012 | -$12,887 | -$7,520 |
| Capital Expenditures | -$82 | -$120 | -$384 | -$275 |
| Free Cash Flow | -$2,919 | -$11,132 | -$13,271 | -$7,795 |